Current treatment options in triple negative breast cancer
2011; IOS Press; Volume: 32; Issue: 1-2 Linguagem: Inglês
10.3233/bd-2010-0304
ISSN1558-1551
AutoresEve T. Rodler, Larissa A. Korde, Julie R. Gralow,
Tópico(s)Advanced Breast Cancer Therapies
ResumoTriple negative breast cancer (TNBC) refers to a subgroup of breast carcinomas that do not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor type 2. This heterogeneous group of tumors has significant over
Referência(s)